CHINA: China's Human Trials of AIDS Vaccine Going 'Smoothly': Researcher

Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.

CHINA: China's Human Trials of AIDS Vaccine Going 'Smoothly': Researcher

Agence France Presse (12.12.05) - Monday, December 12, 2005

Nine months after its launch, China's human trials of an AIDS vaccine are going "smoothly," the Xinhua News Agency reported today. Over the weekend, the last group of 15 Chinese volunteers received the vaccine and reported no side effects in the first 24 hours. "The first 24 hours are a vital period of observation. So far, no volunteers have reported ill reactions. They have entered a relatively stable period for observation," said Chen Jie, deputy-director of the Guangxi regional disease prevention and control center.

Forty-nine people have been inoculated since March 12, when the trials got underway, bringing to an end the first phase of the three-phase trial. Chen said data will be gathered on the volunteers through June 2006; researchers will then decide whether to proceed with the next phase.

Xinhua reported that some 35 human trials of AIDS vaccines are underway worldwide; most are Phase I trials. On Dec. 1, scientists in Sweden said their trial of a DNA vaccine for HIV was going better than expected. Phase I tests among 40 Swedish volunteers have been successfully completed, the Karolinska Institute in Stockholm reported. "We have also failed to find any vaccine-related side effects at all," said professor Eric Sandstroem, chief of testing at the institute.
051212
AD052498

Copyright © 2005 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.